Comorbidities of asthma: Current knowledge and future research needs

Current Opinion in Pulmonary Medicine

Volumn 19, Issue 1, 2013, Pages 36-41

  Cazzola, Mario ^a,b   Segreti, Andrea ^a   Calzetta, Luigino ^b   Rogliani, Paola ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

asthma; comorbidities; obesity; systemic inflammation

Indexed keywords

ADIPOCYTOKINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; IMMUNOGLOBULIN E; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; METHYLXANTHINE; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC RHINITIS; ANXIETY DISORDER; ASTHMA; CARDIOVASCULAR DISEASE; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; GASTROESOPHAGEAL REFLUX; HEART INFARCTION; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; KNOWLEDGE; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; REVIEW;

ASTHMA; COMORBIDITY; DIABETES MELLITUS; GASTROESOPHAGEAL REFLUX; HUMANS; OBESITY; PREVALENCE;

EID: 84871244817     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32835b113a     Document Type: Review

References (58)

1. Boulet LP. Influence of comorbid conditions on asthma. Eur Respir J 2009; 33:897-906.
2. Boulet LP, Boulay ME. Asthma-related comorbidities. Expert Rev Respir Med 2011; 5:377-393.
3. Prosser R, Carleton B,Smith A. The comorbidity burden of the treated asthma patient population in British Columbia. Chronic Dis Can 2010; 30:46-55.
4. Cazzola M, Calzetta L, Bettoncelli G, et al. Asthma and comorbid medical illness. Eur Respir J 2011; 38:42-49.
5. Karlstad O, Nafstad P, Tverdal A, et al. Comorbidities in an asthma population 8-29 years old: a study from the Norwegian Prescription Database. Pharmacoepidemiol Drug Saf 2012; 21:1045-1052.
6. Gershon AS, Guan J, Wang C, et al. Describing and quantifying asthma comorbidity: a population study. PLoS One 2012; 7:e34967.
7. Wouters EF, Reynaert NL, Dentener MA, Vernooy JH. Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection? Proc Am Thorac Soc 2009; 6:638-647.
8. Togias A. Systemic effects of local allergic disease. J Allergy Clin Immunol 2004; 113:S8-S14.
9. Magnussen H, Watz H. Systemic inflammation in chronic obstructive pulmonary disease and asthma: relation with comorbidities. Proc Am Thorac Soc 2009; 6:648-651.
10. Higashimoto Y, Yamagata Y, Taya S, et al. Systemic inflammation in chronic obstructive pulmonary disease and asthma: similarities and differences. Respirology 2008; 13:128-133.
11. Halvani A, Tahghighi F, Nadooshan HH. Evaluation of correlation between airway and serum inflammatory markers in asthmatic patients. Lung India 2012; 29:143-146.
12. Murdoch JR, Lloyd CM. Chronic inflammation and asthma. Mutat Res 2010; 690:24-39.
13. Wood LG, Baines KJ, Fu J, et al. The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest 2012; 142: 86-93.
14. Braunstahl GJ. United airways concept: what does it teach us about systemic inflammation in airways disease? Proc Am Thorac Soc 2009; 6:652-654.
15. Price D. Asthma and allergic rhinitis: linked in treatment and outcomes. Ann Thorac Med 2010; 5:63-64.
16. Rowe-Jones JM. The link between the nose and lung, perennial rhinitis and asthma: is it the same disease? Allergy 1997; 52 (Suppl. 36):20-28.
17. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy 2008; 63 (Suppl. 86):8-160.
18. Lugogo NL, Bappanad D, Kraft M. Obesity, metabolic dysregulation and oxidative stress in asthma. Biochim Biophys Acta 2011; 1810:1120-1126.
19. van Huisstede A, Braunstahl GJ. Obesity and asthma: co-morbidity or causal relationship? Monaldi Arch Chest Dis 2010; 73:116-123.
20. Gustafson B. Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb 2010; 174:332-341.
21. Kattan M, Kumar R, Bloomberg GR, et al. Asthma control, adiposity, and adipokines among inner-city adolescents. J Allergy Clin Immunol 2010; 125:584-592.
22. Farah CS, Salome CM. Asthma and obesity: a known association but unknown mechanism. Respirology 2012; 17:412-421.
23. Thomsen SF, Duffy DL, Kyvik KO, et al. Risk of asthma in adult twins with type 2 diabetes and increased body mass index. Allergy 2011; 66:562-568.
24. Rodbard HW, Bays HE, Gavin JR 3rd, et al. Rate and risk predictors for development of self-reported type-2 diabetes mellitus over a 5-year period: the SHIELD study. Int J Clin Pract 2012; 66:684-691.
25. Song Y, Klevak A, Manson JE, et al. Asthma, chronic obstructive pulmonary disease, and type 2diabetes in the Women's Health Study. Diabetes Res Clin Pract 2010; 90:365-371.
26. Gulcan E, Bulut I, Toker A, Gulcan A. Evaluation of glucose tolerance status in patients with asthma bronchiale. J Asthma 2009; 46:207-209.
27. Rachmiel M, Bloch O, Shaul AA, et al. Young patients with both type 1 diabetes mellitus and asthma have a unique IL-12 and IL-18 secretory pattern. Pediatr Diabetes 2011; 12:596-603.
28. Cazzola M, Calzetta L, Rogliani P, et al. High glucose enhances responsiveness of human airways smooth muscle via Rho/ROCK pathway. Am J Respir Cell Mol Biol 2012; 47:509-516.
29. Havemann BD, Henderson CA, El-Serag HB. The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut 2007; 56:1654-1664.
30. Harding SM, Richter JE. The role of gastroesophageal reflux in chronic cough and asthma. Chest 1997; 111:1389-1402.
31. Ricciardolo FL, Gaston B, Hunt J. Acid stress in the pathology of asthma. J Allergy Clin Immunol 2004; 113:610-619.
32. Parsons JP, Mastronarde JG. Gastroesophageal reflux disease and asthma. Curr Opin Pulm Med 2010; 16:60-63.
33. Appleton S, Ruffin R, Wilson D, et al. Asthma is associated with cardiovascular disease in a representative population sample. Obes Res Clin Pract 2008; 2:91-99.
34. Cazzola M, Calzetta L, Bettoncelli G, et al. Cardiovascular disease in asthma and COPD: a population-based retrospective cross-sectional study. Respir Med 2012; 106:249-256.
35. Schanen JG, Iribarren C, Shahar E, et al. Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities Study. Thorax 2005; 60:633-638.
36. Onufrak S, Abramson J, Vaccarino V. Adult-onset asthma is associated with increased carotid atherosclerosis among women in the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 2007; 195:129-137.
37. 3 receptors augments adenosine-induced coronary flow in isolated mouse heart. Am J Physiol Heart Circ Physiol 2002; 282: H2183-H2189.
38. Lee HM, Truong ST, Wong ND. Association of adult-onset asthma with specific cardiovascular conditions. Respir Med 2012; 106:948-953.
39. Hazarika S, Van Scott MR, Lust RM. Myocardial ischemia-reperfusion injury is enhanced in a model of systemic allergy and asthma. Am J Physiol Heart Circ Physiol 2004; 286:H1720-H1725.
40. Hazarika S, Van Scott MR, Lust RM, Wingard CJ. Pulmonary allergic reactions impair systemic vascular relaxation in ragweed sensitive mice. Vascul Pharmacol 2010; 53:258-263.
41. Gudbjartsson DF, Bjornsdottir US, Halapi E, et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 2009; 41:342-347.
42. Varas-Lorenzo C, Rodriguez LAG, Maguire A, et al. Use of oral corticosteroids and the risk of acute myocardial infarction. Atherosclerosis 2007; 192:376-383.
43. 2-agonists. J Allergy Clin Immunol 2009; 123:124-130.
44. Zhang B, de Vries F, Setakis E, van Staa T-J. The pattern of risk of myo-cardial infarction in patients taking asthma medication: a study with the General Practice Research Database. J Hypertens 2009; 27:1485-1492.
45. Squire I. Shortness of breath, prescription of bronchodilators and the risk of myocardial infarction. J Hypertens 2009; 27:1358-1359.
46. Walters P, Schofield P, Howard L, et al. The relationship between asthma and depression in primary care patients: a historical cohort and nested case control study. PLoS One 2011; 6:e20750.
47. Cluley S, Cochrane GM. Psychological disorder in asthma is associated with poor control and poor adherence to inhaled steroids. Respir Med 2001; 95:37-39.
48. Roy-Byrne PP, Davidson KW, Kessler RC, et al. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry 2008; 30:208-225.
49. Pace TW, Mletzko TC, Alagbe O, et al. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry 2006; 163:1630-1633.
50. Wolkowitz OM, Lupien SJ, Bigler ED. The "steroid dementia syndrome": a possible model of human glucocorticoid neurotoxicity. Neurocase 2007; 13:189-200.
51. Hanania NA, Singh S, El-Wali R, et al. The safety and effects of the b-blocker, nadolol, in mild asthma: an open-label pilot study. Pulm Pharmacol Ther 2008; 21:134-141.
52. Nguyen LP, Singh B, Okulate AA, et al. Complementary anti-inflammatory effects of a b-blocker and a corticosteroid in an asthma model. Naunyn Schmiedebergs Arch Pharmacol 2012; 385:203-210.
53. Lokhandwala T, West-Strum D, Banahan BF, et al. Do statins improve outcomes in patients with asthma on inhaled corticosteroid therapy? A retro spective cohort analysis. BMJ Open 2012; 2:e001279.
54. Nair P, Dasgupta A, Brightling CE, Chung KF. How to diagnose and phenotype asthma. Clin Chest Med 2012; 33:445-457.
55. Lugogo NL, Kraft M, Dixon AE. Does obesity produce a distinct asthma phenotype? J Appl Physiol 2010; 108:729-734.
56. Kring SII, Larsen LH, Holst C, et al. Genotype-phenotype associations in obesity dependent on definition of the obesity phenotype. Obesity Facts 2008; 1:138-145.
57. van Veen IH, TenBrinke A, Sterk PJ, et al. Airway inflammation in obese and nonobese patients with difficult-to-treat asthma. Allergy 2008; 63:570-574.
58. Mahadev S, Farah CS, King GG, Salome CM. Obesity, expiratory flow limitation and asthma symptoms. Pulm Pharmacol Ther 2012;doi:10.1016/j.pupt. 2012.0F5.004. [Epub ahead of print]